Hester Biosciences Ltd // Pharmaceuticals

to
1127.35
Pros:
Company has good consistent profit growth of 25.80% over 5 years
Company has been maintaining a healthy dividend payout of 22.09%
Cons:

Peer Comparison

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Sales Qtr Rs.Cr. Qtr Sales Var % ROCE %
1. Sun Pharma.Inds. 560.10 39.56 134386.16 0.62 1528.99 10.35 6977.10 -2.24 21.01
2. Unichem Labs. 233.15 0.65 1639.91 2.14 -2.38 240.72 -15.05
3. Aurobindo Pharma 583.80 14.12 34205.29 0.43 528.51 -0.74 4049.09 11.19 27.60
4. Cadila Health. 347.95 20.06 35621.12 0.92 590.80 53.26 3250.20 31.77 21.04
5. Lupin 800.65 22.89 36201.65 0.62 -777.60 42.48 4033.83 -5.16 11.24
6. Claris Lifescien 396.55 1.37 2163.88 0.50 -317.43 -1809.37 2.07 -54.51 -10.91
7. Piramal Enterp. 2501.95 29.13 45183.34 1.00 3943.98 19.15 2991.06 22.04 28.33
8. Hester Bios 1127.35 31.38 959.02 0.89 9.01 26.72 37.49 7.33 34.90

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018
24.53 24.00 24.18 28.18 30.72 30.17 29.09 34.93 29.04 38.48 31.93 37.49
16.35 16.56 16.49 18.43 19.97 20.95 19.67 23.25 18.28 23.41 19.31 26.33
Operating Profit 8.18 7.44 7.69 9.75 10.75 9.22 9.42 11.68 10.76 15.07 12.62 11.16
OPM % 33.35% 31.0% 31.8% 34.6% 34.99% 30.56% 32.38% 33.44% 37.05% 39.16% 39.52% 29.77%
Other Income 0.01 0.27 0.59 0.33 0.34 0.11 0.19 0.10 0.55 0.63 0.37 0.32
Depreciation 1.34 1.29 1.43 1.68 1.29 1.34 1.24 1.64 1.38 1.33 1.31 1.43
Interest 1.20 0.52 0.92 1.04 0.78 0.88 0.78 0.78 0.62 0.35 0.75 0.60
Profit before tax 5.64 5.91 5.93 7.36 9.01 7.12 7.59 9.36 9.32 14.02 10.93 9.45
Tax 0.98 1.61 1.17 1.86 2.99 1.12 1.77 2.26 3.13 5.16 4.42 0.43
Net Profit 4.66 4.30 4.76 5.51 6.02 5.99 5.82 7.11 6.19 8.86 6.50 9.01

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
21 32 30 37 41 48 65 69 90 100 125 135
13 15 15 21 23 29 42 43 64 67 84 85
Operating Profit 8 16 14 16 18 18 22 25 25 33 41 49
OPM % 39.95% 52.04% 49.04% 42.93% 43.05% 39.18% 34.47% 36.68% 28.52% 33.11% 32.71% 36.67%
Other Income 0 0 0 0 0 0 0 0 3 0 0 1
Interest 0 2 2 2 2 2 3 6 4 3 3 2
Depreciation 0 3 3 4 4 4 4 5 5 5 5 5
Profit before tax 7 10 8 9 11 12 15 14 18 24 33 43
Tax 2 3 3 3 3 4 5 4 4 5 8 13
Net Profit 5 7 4 6 7 7 9 10 13 19 24 30
EPS (unadj) 9.58 13.14 8.71 11.12 14.07 13.58 11.05 11.52 15.82 22.60 29.32 35.92
Dividend Payout % 20.16% 18.43% 27.38% 25.83% 23.91% 7.28% 17.56% 16.86% 18.85% 18.15% 18.08% 27.84%
Compounded Sales Growth
10 Years:18.14%
5 Years:15.75%
3 Years:14.52%
TTM:9.63%
Compounded Profit Growth
10 Years:22.99%
5 Years:25.80%
3 Years:36.66%
TTM:22.53%
Return on Equity
10 Years:18.09%
5 Years:19.87%
3 Years:22.20%
TTM:22.77%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
5 5 5 5 5 5 8 8 8 8 8 8
Reserves 22 28 31 35 41 54 59 67 75 91 113 137
22 20 18 20 21 16 24 35 38 38 39 42
Other Liabilities 15 16 21 19 14 15 22 17 17 19 22 23
Total Liabilities 65 70 77 80 81 91 114 128 140 158 183 212
34 40 40 39 39 36 34 50 56 61 60 66
CWIP 0 0 0 0 0 6 24 13 14 10 21 30
Investments 0 0 0 0 2 2 2 3 8 8 8 14
30 29 36 41 40 46 53 61 60 78 93 101
Total Assets 65 70 77 80 81 91 114 128 140 158 183 212

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
17 9 7 16 7 12 13 11 20 18 27 31
-28 -9 -3 -3 -6 -7 -17 -13 -11 -5 -15 -26
17 -7 -4 -12 -1 -5 3 2 -5 -11 -5 -5
Net Cash Flow 6 -6 0 0 0 0 0 0 3 1 6 0